TRIFLUOPERAZINE HYDROCHLORIDE | A040209 | MYLAN PHARMACEUTICALS INC
Highest NADAC/Unit
$1.27
per ea
Lowest NADAC/Unit
$0.4310
per ea
Brand NDCs
0
Generic NDCs
8
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 51079057520TRIFLUOPERAZINE 10 MG TABLET | $1.27 | EA | Generic | — | 2026-06-17 |
| 00378241001TRIFLUOPERAZINE 10 MG TABLET | $1.27 | EA | Generic | — | 2026-06-17 |
| 51079057420TRIFLUOPERAZINE 5 MG TABLET | $0.8947 | EA | Generic | — | 2026-06-17 |
| 00378240501TRIFLUOPERAZINE 5 MG TABLET | $0.8947 | EA | Generic | — | 2026-06-17 |
| 51079057320TRIFLUOPERAZINE 2 MG TABLET | $0.6538 | EA | Generic | — | 2026-06-17 |
| 00378240201TRIFLUOPERAZINE 2 MG TABLET | $0.6538 | EA | Generic | — | 2026-06-17 |
| 00378240101TRIFLUOPERAZINE 1 MG TABLET | $0.4310 | EA | Generic | — | 2026-06-17 |
| 51079057220TRIFLUOPERAZINE 1 MG TABLET | $0.4310 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.